News
5d
MedPage Today on MSNFracture Risk Down With Osteoporosis Drug in Metastatic Prostate Cancer
With regard to the choice of bone-protecting agent, denosumab (Xgeva) improved bone density and reduced fracture risk in a ...
Paul Henderson received his official diagnosis of Stage 2 prostate cancer on June 17. In this weekly diary, he will be ...
Prostate cancer is the most common form of cancer among men in England, with cases surging by 25 per cent between 2019 and ...
Ryne Sandberg, a legendary second baseman for the Chicago Cubs, has passed away at 65 years old following a battle against ...
One in eight men in the U.S. will be diagnosed with prostate cancer in their lifetime, according to the American Cancer ...
I expected that becoming cancer-free would mean getting my old life back. Nothing could be further from the truth.
Explore more
11h
US Weekly on MSNChicago Cubs Legend Ryne Sandberg Dead at 65 After Prostate Cancer Battle
Ryne Sandberg, former Chicago Cubs legend, has passed away at 65 following a tough battle with prostate cancer. Here’s what ...
Prostate cancer is the second leading cause of death in men right behind heart disease. Patients with this cancer often don’t ...
Prostate cancer is one of the most common cancers in the world. While many prostate cancers grow slowly and remain localized, ...
Longtime Chicago Cubs star and Hall of Famer Ryne Sandberg died on Monday, the team announced.
In a significant advancement for prostate cancer research, a first-of-its-kind study led by Emory researchers uncovered how ...
A recent trial reveals metformin does not enhance survival in metastatic prostate cancer but offers significant metabolic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results